NCT06852378 Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries
| NCT ID | NCT06852378 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Iliopsoas Nerve Block |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2025-03-01 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries
Eligibility Criteria
Inclusion Criteria: * Age from 18 to 65 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I and II. * Patients who are scheduled for elective surgical correction of hip fracture either through open fracture internal fixation (ORIF), partial hip arthroplasty or total hip arthroplasty. Exclusion Criteria: * Refusal to participate. * Coagulopathy. * Patients with a history of drug allergies to study drugs. * Inability to cooperate.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06852378 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Iliopsoas Nerve Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06852378 currently recruiting?
Yes, NCT06852378 is actively recruiting participants. Contact the research team at hazem.khaled@med.asu.edu.eg for enrollment information.
Where is the NCT06852378 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06852378 clinical trial?
NCT06852378 is sponsored by Ain Shams University. The trial plans to enroll 80 participants.